
Building sustainable solutions for tomorrow’s therapies
Cencora ThinkLive Cell and Gene Therapy Virtual Summit 2025
Participants gained valuable knowledge about navigating the complexities of drug development, including the latest FDA and EMA programs designed to accelerate therapy approvals. Engaging discussions included practical strategies for effective stakeholder communication, the integration of logistics in therapy distribution, and the implications of new regulations on market access. The summit concluded with a forward-looking fireside chat, highlighting the exciting prospects for the future of cell and gene therapies and the collaborative efforts needed to shape sustainable solutions for tomorrow’s healthcare landscape.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.